Skip to content
The Nexus
HEALTHJun 20 · 12:55 UTCNY POSTJeanne Erickson

Ozempic and Wegovy may strengthen bones in Type 2 diabetes patients, study finds

A new study suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may strengthen bones in Type 2 diabetes patients by 15%. This effect was described as an unexpected side benefit of the weight loss drugs.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting